Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of CCND3 mutations in diffuse large B-cell lymphoma.

Annals of hematology - 1 Dec 2024

Hua Wei, Li Yue, Yin Hua, Du Kai-Xin, Zhang Xin-Yu, Wu Jia-Zhu, Liang Jun-Heng, Shen Hao-Rui, Gao Rui, Li Jian-Yong, Wang Li, Liang Jin-Hua, Xu Wei

Abstract excerpt

Diffuse large B-cell lymphoma (DLBCL), accounts for 30-40% of newly diagnosed lymphomas, has an overall cure rate of approximately 60%. Despite previous reports suggesting a negative prognostic association between CCND3 mutations and Burkitt lymphoma, their prognostic implications in DLBCL remain controversial. To investigate this, we evaluated CCND3 mutation status in 2059 DLBCL patient samples from four...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma, Large B-Cell, Diffuse

Share to Mutation

Share to Prognosis

Share to Survival Rate

Source

Identifiers

PMID: 38886191
DOI: 10.1007/s00277-024-05844-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of CCND3 mutations in diffuse large B-cell lymphoma.PMID 38886191Read ↗

Analysis of CCND3 mutations in diffuse large B-cell lymphomaSemantic proximity Read ↗

Next generation sequencing and the management of diffuse large B-cell lymphoma: from whole exome analysis to targeted therapy.Semantic proximity Read ↗

Genetic heterogeneity of diffuse large B-cell lymphoma.Semantic proximity Read ↗

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.Semantic proximity Read ↗

Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristicsSemantic proximity Read ↗

Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

The role of next-generation sequencing in understanding the genomic basis of diffuse large B cell lymphoma and advancing targeted therapies.Semantic proximity Read ↗

The genetic landscape of mutations in Burkitt lymphoma.Semantic proximity Read ↗

In Silico Identification and Functional Characterization of Genetic Variations across DLBCL Cell Lines.Semantic proximity Read ↗

Whole-Genome/Exome Sequencing Uncovers Mutations and Copy Number Variations in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous SystemSemantic proximity Read ↗

Molecular Pathogenesis of Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Simplified algorithm for genetic subtyping in diffuse large B-cell lymphomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.